Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease

The aim of the investigation was to study the prevalence, clinical and prognostic values of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease. Examination was performed on 90 patients with diabetic nephropathy (DN...

Full description

Saved in:
Bibliographic Details
Main Authors: O. A. Pavlenko, T. A. Kolosovskaya, O. F. Sibireva, Ye. Yu. Khitrinskaya, V. Yu. Grankina, V. V. Kalyuzhin
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2009-08-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/1923
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839570190764867584
author O. A. Pavlenko
T. A. Kolosovskaya
O. F. Sibireva
Ye. Yu. Khitrinskaya
V. Yu. Grankina
V. V. Kalyuzhin
author_facet O. A. Pavlenko
T. A. Kolosovskaya
O. F. Sibireva
Ye. Yu. Khitrinskaya
V. Yu. Grankina
V. V. Kalyuzhin
author_sort O. A. Pavlenko
collection DOAJ
description The aim of the investigation was to study the prevalence, clinical and prognostic values of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease. Examination was performed on 90 patients with diabetic nephropathy (DN) and 180 patients with chronic glomerulonephritis (CG). In addition to complete clinical and instrumental examination accepted in specialised clinic, with the help of polymerase chain reaction diagnostics of polymorphism of the referred above genes (samples of genomic DNA were obtained from peripheral blood leukocytes) was conducted. It was found that the protrombogenic mutations under investigation which are detected in patients with DN and CG more often than in healthy subjects are associated with development of hypercoagulation syndrome and higher risk of renal failure.
format Article
id doaj-art-958e96e2a35243669ca2b47c21d7a84b
institution Matheson Library
issn 1682-0363
1819-3684
language English
publishDate 2009-08-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj-art-958e96e2a35243669ca2b47c21d7a84b2025-08-04T16:45:30ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842009-08-0184(2)808510.20538/1682-0363-2009-4(2)-80-851416Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney diseaseO. A. Pavlenko0T. A. Kolosovskaya1O. F. Sibireva2Ye. Yu. Khitrinskaya3V. Yu. Grankina4V. V. Kalyuzhin5Сибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетThe aim of the investigation was to study the prevalence, clinical and prognostic values of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease. Examination was performed on 90 patients with diabetic nephropathy (DN) and 180 patients with chronic glomerulonephritis (CG). In addition to complete clinical and instrumental examination accepted in specialised clinic, with the help of polymerase chain reaction diagnostics of polymorphism of the referred above genes (samples of genomic DNA were obtained from peripheral blood leukocytes) was conducted. It was found that the protrombogenic mutations under investigation which are detected in patients with DN and CG more often than in healthy subjects are associated with development of hypercoagulation syndrome and higher risk of renal failure.https://bulletin.ssmu.ru/jour/article/view/1923diabetic nephropathychronic glomerulonephritisprotrombogenic genotypesprevalenceprognosis
spellingShingle O. A. Pavlenko
T. A. Kolosovskaya
O. F. Sibireva
Ye. Yu. Khitrinskaya
V. Yu. Grankina
V. V. Kalyuzhin
Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease
Бюллетень сибирской медицины
diabetic nephropathy
chronic glomerulonephritis
protrombogenic genotypes
prevalence
prognosis
title Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease
title_full Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease
title_fullStr Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease
title_full_unstemmed Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease
title_short Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease
title_sort prevalence clinical and prognostic value of polymorphism of genes ii v factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease
topic diabetic nephropathy
chronic glomerulonephritis
protrombogenic genotypes
prevalence
prognosis
url https://bulletin.ssmu.ru/jour/article/view/1923
work_keys_str_mv AT oapavlenko prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease
AT takolosovskaya prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease
AT ofsibireva prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease
AT yeyukhitrinskaya prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease
AT vyugrankina prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease
AT vvkalyuzhin prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease